Navigating PMR and GCA Treatments

This chapter examines the intricate treatment landscape for Polymyalgia Rheumatica (PMR) and Giant Cell Arteritis (GCA), highlighting recent advancements like serolimumab and tocilizumab. It discusses treatment challenges, including the impact on patients' lives, the significance of disease history, and emerging therapies being explored in clinical trials.